Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents

Bioorganic Chemistry

Volumn 35, Issue 1, 2007, Pages 25-34

  Varaprasad, Chamakura V N S ^a   Ramasamy, Kanda S ^a   Girardet, Jean Luc ^a   Gunic, Esmir ^a   Lai, Vicky ^a   Zhong, Weidong ^a   An, Haoyun ^a   Hong, Zhi ^a  

^a Drug Discovery   (United States)

Author keywords

HCV NS5B inhibitors; Pyrrolo 2,3 d pyrimidine nucleosides; Toyocamycin

Indexed keywords

4 METHYLAMINO 7 (BETA DEXTRO RIBOFURANOSYL)PYRROLO[2,3 D]PYRIMIDINE 5 CARBOXAMIDOXIME; 4 METHYLTHIO 7 (BETA DEXTRO RIBOFURANOSYL)PYRROLO[2,3 D]PYRIMIDINE 5 CARBONITRILE; 4 METHYLTHIO 7 (BETA DEXTRO RIBOFURANOSYL)PYRROLO[2,3 D]PYRIMIDINE 5 CARBOXAMIDOXIME; PYRROLO[2,3 D]PYRIMIDINE DERIVATIVE; TOYOCAMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIVIRAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS C; PRIORITY JOURNAL; REPLICON;

ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PYRIMIDINE NUCLEOSIDES; PYRIMIDINES; PYRROLES; RNA REPLICASE; TOYOCAMYCIN; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 33846212716     PISSN: 00452068     EISSN: 10902120     Source Type: Journal    
DOI: 10.1016/j.bioorg.2006.07.003     Document Type: Article

References (25)

1. Chun B.K., Wang P., Hassan A., Du J., Tharnish P.M., Stuyver L.J., Otto M.J., Schinazi R.F., and Watanabe K.A. Tetrahedron Lett. 46 (2005) 2825-2827
2. Shi J., Du J., Ma T., Pankiewicz K.W., Patterson S.E., Tharnish P.M., McBrayer T.R., Stuyver L.J., Otto M.J., and Chu C.K. Bioorg. Med. Chem. 13 (2005) 1641-1652
3. De Clercq E.J. Clin. Virol. 30 (2004) 115-133
4. Griffith R.C., Lou L., Roberts C.D., and Schmitz U. Annu. Rep. Med. Chem. 39 (2004) 223-237
5. Walker M.P., and Hong Z. Curr. Opin. Pharmcol. 2 (2002) 534-540
6. Okuse C., Rinaudo J.A., Farrar K., Wells F., and Korba B.E. Antiviral Res. 65 (2005) 23-34
7. Asahina Y., Izumi N., Enomoto N., Uchihara M., Kurosaki M., Onuki Y., Nishimura Y., Ueda K., Tsuchiya K., Nakanishi H., Kitamura T., and Miyake S. J. Hepatol. 43 40 (2005) 623-629
8. Smith K.L., Lai V.C.H., Prigaro B.J., Ding Y., Gunic E., Girardet J.-L., Zhong W., Hong Z., Lang S., and An H. Bioorg. Med. Chem. Lett. 14 (2004) 3517-3520
9. Ding Y., Girardet J.-L., Smith K.L., Larson G., Prigaro B., Lai V.C.H., Zhong W., and Wu J.Z. Bioorg. Med. Chem. Lett. 15 (2005) 675-678
10. Ding Y., An H., Hong Z., and Girardet J.-L. Bioorg. Med. Chem. Lett. 15 3 (2005) 725-727
11. Porcari A.R., and Townsend L.B. Synth. Commn. 28 20 (1998) 3835-3843
12. Porcari A.R., and Townsend L.B. Nucleosides Nucleotides 18 (1999) 153-159
13. Bergstrom D.E., Brattesani A.J., Ogawa M.K., and Schweickert M.J. J. Org. Chem. 46 (1981) 1423-1431
14. Maruyama T., Wotring L.L., and Townsend L.B. J. Med. Chem. 26 (1983) 25-29
15. Clercq E.D., Balzarini J., Madej D., Hansske F., and Robins M.J. J. Med. Chem. 30 (1987) 481-486
16. Krawczyk S.H., Rodriguez M.B., Nassiri M.R., Kern E.R., Wotring L.L., Drach J.C., and Townsend L.B. J. Med. Chem. 33 (1990) 3160-3169
17. Krawczyk S.H., Nassiri M.R., Kucera L.S., Kern E.R., Ptak R.G., Wotring L.L., Drach J.C., and Townsend L.B. J. Med. Chem. 38 (1995) 4106-4114
18. Gupta P.K., Daunert S., Nassiri M.R., Wotring L.L., Drach J.C., and Townsend L.B. J. Med. Chem. 32 (1989) 402-408
19. Gupta P.K., Nassiri M.R., Coleman L.A., Wotring L.L., Drach J.C., and Townsend L.B. J. Med. Chem. 32 (1989) 1420-1425
20. Saxena N.K., Coleman L.A., Drach J.C., and Townsend L.B. J. Med. Chem. 33 (1990) 1980-1983
21. Renau T.E., Wotring L.L., Drach J.C., and Townsend L.B. J. Med. Chem. 39 (1996) 873-880
22. Renau T.E., Kennedy C., Ptak R.G., Breitenbach J.M., Drach J.C., and Townsend L.B. J. Med. Chem. 39 (1996) 34470-34476
23. Shim J., Larson G., Lai V., Naim S., and Wu J.Z. Antiviral Res. 58 (2003) 243
24. Hinshaw B.C., Gerster J.F., Robins R.K., and Townsend L.B. J. Org. Chem. 35 (1970) 236-241
25. Hinshaw B.C., Leonoudakis O., Schra K.H., and Townsend L.B. J.C.S. Perkin Trans. I (1975) 1248-1253